Sort the Following Results By:

DateTitleKnowledge Type
15 August 2017
Record-Breaking Recognition for Kilpatrick Townsend in The Best Lawyers in America® 2018 News Releases
30 May 2017
Kilpatrick Townsend Achieves Recognition From Chambers USA 2017 News Releases
10 April 2017
Kilpatrick Townsend Assists AT&T on Straight Path Deal News Releases
28 February 2017
Kilpatrick Townsend Once Again Achieves Recognition for 2017 Georgia Super Lawyers News Releases
23 January 2017
Kilpatrick Townsend Attorneys Named 2016 “Legal Elite” News Releases
16 August 2016
Kilpatrick Townsend Earns Record-Breaking Recognition in Annual Best Lawyers in America 2017 News Releases
31 May 2016
Kilpatrick Townsend Once Again Achieves Recognition From Chambers USA 2016 News Releases
07 December 2015
Kilpatrick Townsend Attorneys Named 2015 “Legal Elite” News Releases
19 August 2015
Kilpatrick Townsend Earns Record-Breaking Recognition in Annual Best Lawyers in America 2016 News Releases
22 May 2015
Kilpatrick Townsend Once Again Achieves Recognition From Chambers USA 2015 News Releases
26 February 2015
Kilpatrick Townsend Once Again Achieves Recognition for 2015 Georgia Super Lawyers News Releases
10 December 2014
Kilpatrick Townsend Attorneys Named 2014 “Legal Elite” News Releases
20 August 2014
Kilpatrick Townsend Earns Record-Breaking Recognition in Annual Best Lawyers in America 2015 News Releases
28 May 2014
Kilpatrick Townsend Once Again Earns Record-Breaking Recognition From CHAMBERS USA 2014 News Releases
26 February 2014
Kilpatrick Townsend Once Again Achieves Recognition for Georgia Super Lawyers News Releases

Who We Are

Suite 2800, 1100 Peachtree Street NE
Atlanta, GA, 30309-4528
USA
t +1 404.815.6653
f +1 404.541.3204
Suite 900, 607 14th Street, NW
Washington, DC, 20005-2018
USA
t +1 202.824.1428

Lynn E. Fowler

Experience Highlights

Global License, Development and Commercialization agreement for Biotest AG
Served as lead counsel in representing Biotest AG (Biotest), a German publicly traded biotechnology company, in signing a global License, Development more
$2 Billion Public Offering for Delta Air Lines, Inc.
Represented Delta Air Lines, Inc. in its $2 billion public bond offering. more
Cash tender offer for $2.8 billion of corporate bonds
Represented Reynolds American in a cash tender offer for $2.8 billion of its outstanding corporate bonds. more
Bolt-On Acquisition of Medical Device Manufacturer
Represented French private equity fund sponsor and its portfolio company, a Franco-American manufacturer of surgical devices, in the leveraged more